InvestorsHub Logo
Followers 49
Posts 11381
Boards Moderated 0
Alias Born 06/15/2014

Re: alm2 post# 380885

Sunday, 06/19/2022 2:37:20 PM

Sunday, June 19, 2022 2:37:20 PM

Post# of 426436
Alm, you make some excellent points that need to be hammered home:

1) "A big scale pharma company can make money out of vascepa"

2) "Amarin can not" -

3) "The present board and present plans will leave company profit less and cash reducing for several years to come"

4) "Denner I feel want this done in 12 months - he has been in it for nearly a year already"

All of those are self-explanatory and quite clear. As far as #4, you are quite correct that his first purchases of Amarin stock were a year ago, and I am surprised that not much has changed with Amarin. I would think Denner has been trying quietly and patiently to whisper in management's ear, but I think enough time has passed and he now is going to take a more direct approach. We all have to hope that he succeeds and doesn't throw in the towel..

And as far as a valuation for a BO, Amarin has to realize that it cannot expect a value based on what BP can do with V.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News